Dual roles of SBSN in renal cancer progression and tumor thrombus: Cell-autonomous NF-κB-CD44 axis and IFI6-driven paracrine angiogenesis.

Authors

Yuedian Ye, Jinbin Xu, Weihao Liu, Zhansen Huang, Xiaoming Li, Jiang Li, Yuanpeng Liao, Sam Un Cheong, Zifeng Xu, Gengguo Deng, Tiantian Wang, Jinming Di

Published in

iScience. Volume 29. Issue 8. Pages 116905. Aug 21, 2026. Epub Jul 23, 2026.

Abstract

Renal cell carcinoma (RCC) is highly vascular and prone to venous invasion and tumor thrombus (TT) formation, though its underlying molecular mechanisms remain unclear. In this study, we found suprabasin (SBSN) was upregulated in RCC and enriched in TT, associated with poor prognosis. SBSN promoted RCC cell proliferation, migration, and invasion via the NF-κB-CD44 axis, and its knockdown inhibited tumor growth and affected epithelial-mesenchymal transition in vivo. Clinically, SBSN expression in RCC tissue positively correlates with microvessel density. Mechanistically, SBSN drove angiogenesis paracrinally by upregulating interferon alpha-inducible protein 6 (IFI6) in endothelial cells, which in turn inhibits endothelial cell apoptosis and promotes tube formation. Collectively, SBSN acts both intrinsically (NF-κB-CD44 axis) to boost tumor aggressiveness and extrinsically (SBSN-IFI6 axis) to promote angiogenesis. This study positions SBSN as a potential prognostic biomarker and therapeutic target to disrupt both tumor growth and vascular support in advanced RCC.

PMID:
42542584
Bibliographic data and abstract were imported from PubMed on 02 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.